Explore 3 Stock Ideas & Industry Insights Download Free Report

18889881171
Shopping Cart 0
countryflagUS
Login

Cronos Group Inc

Healthcare US CRON

2.8USD
0.09(3.32%)

Last update at 2026-06-04T20:00:00Z

Day Range

2.712.85
LowHigh

52 Week Range

1.783.43
LowHigh

Fundamentals

  • Previous Close 2.71
  • Market Cap1050.01M
  • Volume990752
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-3.35300M
  • Revenue TTM146.59M
  • Revenue Per Share TTM0.38
  • Gross Profit TTM 58.40M
  • Diluted EPS TTM-0.02

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -17.12000M 36.59M -73.66900M -134.55900M -397.13500M
Minority interest -6.51800M 1.06M 0.33M 0.00000M -1.09700M
Net income -9.44700M 41.08M -73.96300M -168.73400M -396.70400M
Selling general administrative 42.00M 55.21M 58.23M 86.29M 106.63M
Selling and marketing expenses 21.76M 21.60M 22.70M 22.28M 44.94M
Gross profit 62.76M 25.20M 11.91M 11.97M -17.53400M
Reconciled depreciation 14.23M 9.34M 9.56M 13.12M 15.40M
Ebit -17.12000M -59.54900M -79.91000M -116.01200M 6.79M
Ebitda -15.00100M -50.21300M -71.80000M -59.18500M 22.19M
Depreciation and amortization 2.12M 9.34M 8.11M 56.83M 15.40M
Non operating income net other - - - - 154.39M
Operating income -2.92900M -76.52900M -84.80000M -116.01200M 6.79M
Other operating expenses 196.29M 194.14M 172.04M 207.92M 271.35M
Interest expense - - - 22.54M 0.03M
Tax provision -14.19100M -3.43600M 29.13M 34.17M -0.43100M
Interest income 39.96M 52.02M 46.54M 22.54M 9.10M
Net interest income 39.96M 52.02M 46.53M 22.54M 9.07M
Extraordinary items - - - - -
Non recurring - - - - 363.68M
Other items - - - - -
Income tax expense -7.67300M -3.43600M -3.23000M 34.17M -0.43100M
Total revenue 193.36M 117.61M 87.24M 91.90M 74.44M
Total operating expenses 65.69M 101.73M 96.71M 127.98M 179.38M
Cost of revenue 130.60M 92.42M 75.33M 79.94M 91.97M
Total other income expense net -14.19100M 113.11M 11.13M -18.54700M -403.92000M
Discontinued operations - - - - -0.50000M
Net income from continuing ops -2.92900M 40.02M -115.02500M -168.73400M -396.70400M
Net income applicable to common shares - - - -168.73400M -396.10700M
Preferred stock and other adjustments - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 1197.14M 1166.31M 1134.25M 1213.01M 1397.74M
Intangible assets 8.89M 11.13M 21.08M 26.70M 18.08M
Earning assets - - - - -
Other current assets 8.34M 14.39M 5.38M 7.11M 8.97M
Total liab 54.18M 55.33M 43.74M 72.05M 63.46M
Total stockholder equity 1093.90M 1064.06M 1093.95M 1143.88M 1337.24M
Deferred long term liab - - - - 0.08M
Other current liab 36.21M 19.86M 28.07M 55.62M 14.38M
Common stock 661.78M 669.88M 610.58M 611.32M 595.50M
Capital stock 662.98M 669.88M 613.73M 611.32M 595.50M
Retained earnings 447.76M 457.71M 414.59M 490.68M 659.42M
Other liab - - - 1.38M 1.99M
Good will 66.48M 63.45M 1.05M 1.03M 1.10M
Other assets - 0.13M 0.00000M 72.54M 80.73M
Cash 791.79M 858.80M 665.87M 764.64M 886.97M
Cash and equivalents - - - - -
Total current liabilities 48.19M 49.70M 41.19M 68.12M 54.37M
Current deferred revenue - - 0.06M - 26.07M
Net debt -790.28500M -856.78700M -663.32677M -760.76800M -877.16700M
Short term debt 0.34M 1.02M 0.99M 1.33M 2.71M
Short long term debt - - - - -
Short long term debt total 1.51M 2.02M 2.54M 3.88M 9.81M
Other stockholder equity 662.98M 669.88M 48.20M 42.68M 32.47M
Property plant equipment - - - 62.83M 82.95M
Total current assets 944.09M 936.11M 928.53M 960.16M 1079.72M
Long term investments 7.66M 2.81M 54.74M 89.75M 135.16M
Net tangible assets - - - 1116.15M 1318.07M
Short term investments 40.00M 0.00000M 191.25M 113.08M 117.68M
Net receivables 57.20M 29.77M 35.69M 37.77M 33.29M
Long term debt - - - - -
Inventory 46.75M 33.15M 30.34M 37.56M 32.80M
Accounts payable 11.64M 16.97M 12.07M 11.16M 11.22M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -2.96700M
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -16.84200M -63.52500M 20.57M -0.79700M 49.87M
Additional paid in capital - - - - -
Common stock total equity - - - - 595.50M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - 659.42M
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 20.85M 15.53M 0.04M 72.54M 0.10M
Deferred long term asset charges - - - - -
Non current assets total 253.05M 230.07M 205.72M 252.85M 318.02M
Capital lease obligations 1.51M 2.02M 2.55M 3.88M 9.81M
Long term debt total - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments -45.10700M 175.15M 17.07M -1.84200M -14.69900M
Change to liabilities - - - -0.86300M -2.37300M
Total cashflows from investing activities -77.89921M 175.15M -59.49900M -1.84200M -28.89800M
Net borrowings - - - - -
Total cash from financing activities -20.25345M -1.23100M -1.03000M -2.89700M -13.44200M
Change to operating activities - - - -2.75800M 1.97M
Net income -9.44700M 40.02M -74.55300M -168.73400M -397.20400M
Change in cash -67.94111M 189.51M -95.35300M -122.32900M -191.05000M
Begin period cash flow 858.80M 669.29M 764.64M 886.97M 1078.02M
End period cash flow 791.79M 858.80M 669.29M 764.64M 886.97M
Total cash from operating activities 26.32M 18.84M -42.83500M -88.94800M -153.61600M
Issuance of capital stock - - - - -
Depreciation 14.23M 9.34M 8.11M 13.12M 15.40M
Other cashflows from investing activities - 8.41M 18.41M 0.45M 1.65M
Dividends paid - - 0.34M 0.38M -
Change to inventory -10.57697M 5.28M 7.40M -7.21700M 11.56M
Change to account receivables -26.20382M -0.91700M -6.58700M -2.71100M -13.16300M
Sale purchase of stock -9.91152M 0.00000M -1.36472M - -
Other cashflows from financing activities -10.34193M -1.23100M -1.03000M -2.51300M -13.44200M
Change to netincome - - - 46.00M 229.09M
Capital expenditures 26.17M 13.15M 3.42M 5.03M 12.26M
Change receivables - - - - -9.32500M
Cash flows other operating - - - - -4.12600M
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -195.95600M
Change in working capital -35.01644M -0.31100M -26.46800M 20.66M -2.00500M
Stock based compensation 7.05M 8.70M 8.77M 15.12M 10.15M
Other non cash items 61.34M -38.90400M 41.31M 30.89M -2.17900M
Free cash flow 0.15M 5.69M -46.25800M -93.98000M -165.87800M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CRON
Cronos Group Inc		 0.09 3.32% 2.80 - 32.26 7.16 0.95 1.47 1.90
ZTS
Zoetis Inc		 1.93 2.49% 79.52 40.18 30.96 10.67 17.60 11.27 26.18
MKKGY
Merck KGaA ADR		 1.31 4.22% 32.32 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien		 14.53 9.74% 163.71 21.73 14.95 3.16 2.15 3.56 12.82
GALDY
GALDERMA GROUP AG		 -0.34 0.83% 40.58 74.21 41.67 8.64 5.55 9.15 42.22

Reports Covered

Stock Research & News

View All

Profile

Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and tinctures under the Spinach, Lord Jones, Lit, and Peace Naturals brand names. The company is headquartered in Stayner, Canada.

Cronos Group Inc

4491 Concession Road 12, Stayner, ON, Canada, L0M 1S0

Key Executives

Name Title Year Born
Mr. Michael Ryan Gorenstein J.D. Pres, CEO & Chairman 1987
Ms. Shannon Buggy Sr. VP & Global Head of People 1970
Ms. Anna Shlimak Sr. VP of Corp. Affairs & Strategy 1986
Mr. James Holm Chief Financial Officer NA
Mr. Carlos Cortez VP, Controller & Principal Accounting Officer 1973
Mr. Shayne J. Laidlaw Director of Investor Relations & Strategy NA
Mr. Terry Gregory-Joseph Doucet Sr. VP of Legal & Regulatory Affairs and Corp. Sec. 1990
Mr. Jeffrey David Jacobson Chief Growth Officer 1986
Mr. Arye Weigensberg Head of R&D NA
Mr. Kevin B Gifford VP of Fin. NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.